GB0413726D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0413726D0
GB0413726D0 GBGB0413726.1A GB0413726A GB0413726D0 GB 0413726 D0 GB0413726 D0 GB 0413726D0 GB 0413726 A GB0413726 A GB 0413726A GB 0413726 D0 GB0413726 D0 GB 0413726D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0413726.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lauras AS
Original Assignee
Lauras AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lauras AS filed Critical Lauras AS
Priority to GBGB0413726.1A priority Critical patent/GB0413726D0/en
Publication of GB0413726D0 publication Critical patent/GB0413726D0/en
Priority to DK05755520.3T priority patent/DK1765844T3/da
Priority to JP2007516050A priority patent/JP5044750B2/ja
Priority to CNA2005800259528A priority patent/CN101001865A/zh
Priority to CA2568907A priority patent/CA2568907C/en
Priority to US11/629,908 priority patent/US8153609B2/en
Priority to EP05755520.3A priority patent/EP1765844B1/en
Priority to PCT/GB2005/002418 priority patent/WO2005123755A2/en
Priority to ES05755520.3T priority patent/ES2496946T3/es
Priority to AU2005254790A priority patent/AU2005254790B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB0413726.1A 2004-06-18 2004-06-18 Compounds Ceased GB0413726D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds
AU2005254790A AU2005254790B2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
CA2568907A CA2568907C (en) 2004-06-18 2005-06-20 8-carbyl substituted cyclic adenosine-3',5'-monophosphorothiolate compounds as camp modulators
JP2007516050A JP5044750B2 (ja) 2004-06-18 2005-06-20 プリンヌクレオチド誘導体
CNA2005800259528A CN101001865A (zh) 2004-06-18 2005-06-20 嘌呤核苷酸衍生物
DK05755520.3T DK1765844T3 (da) 2004-06-18 2005-06-20 Purin-nukleotidderivater
US11/629,908 US8153609B2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
EP05755520.3A EP1765844B1 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
PCT/GB2005/002418 WO2005123755A2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
ES05755520.3T ES2496946T3 (es) 2004-06-18 2005-06-20 Derivados de nucleótidos de purina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds

Publications (1)

Publication Number Publication Date
GB0413726D0 true GB0413726D0 (en) 2004-07-21

Family

ID=32750205

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0413726.1A Ceased GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds

Country Status (10)

Country Link
US (1) US8153609B2 (https=)
EP (1) EP1765844B1 (https=)
JP (1) JP5044750B2 (https=)
CN (1) CN101001865A (https=)
AU (1) AU2005254790B2 (https=)
CA (1) CA2568907C (https=)
DK (1) DK1765844T3 (https=)
ES (1) ES2496946T3 (https=)
GB (1) GB0413726D0 (https=)
WO (1) WO2005123755A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
GB0618235D0 (en) * 2006-09-15 2006-10-25 Lauras As Process
LT2448968T (lt) * 2009-06-29 2021-05-10 Bioarctic Ab Antikūnai, atpažįstantys n gale sutrumpintas amiloido protofibriles/oligomerus
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
CA2819041A1 (en) * 2010-12-22 2012-06-28 Alios Biopharma, Inc. Cyclic nucleotide analogs
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
SG10201913554YA (en) 2011-12-22 2020-03-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
HK1206362A1 (zh) 2012-03-21 2016-01-08 Alios Biopharma, Inc. 硫代氨基磷酸酯核苷酸前藥的固體形式
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US20240182511A1 (en) * 2021-04-09 2024-06-06 Merck Sharp & Dohme Llc Novel forms of cyclic dinucleotide compounds
CN117999269A (zh) 2021-09-06 2024-05-07 米雷卡医药有限公司 用于生产环状鸟苷-单磷酸酯类似物的改进方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968101A (en) * 1974-12-20 1976-07-06 Icn Pharmaceuticals, Inc. 8-Substituted cyclic nucleotides by free radical alkylation and acylation
WO1989007108A1 (en) 1988-02-01 1989-08-10 Bernd Jastorff Process for producing nucleoside-3',5'-cyclophosphates and nucleoside-3',5'-cyclothiophosphates
WO1993021929A1 (en) 1992-05-01 1993-11-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Phosphorothioate derivatives of cyclic amp analogues
US5625056A (en) * 1992-05-26 1997-04-29 Biolog Life Science Institute Derivatives of cyclic guanosine-3',5'-monophosphorothioate
NO971997D0 (no) 1997-04-29 1997-04-29 Kjetil Tasken Bruk av immunmodulerende midler
JP4902958B2 (ja) * 2002-06-07 2012-03-21 ユニバーシテール・メディッシュ・セントラム・ユトレヒト ｃＡＭＰによって直接活性化される交換タンパク質（Ｅｐａｃ）の活性をモジュレートするための新規な化合物

Also Published As

Publication number Publication date
CN101001865A (zh) 2007-07-18
ES2496946T3 (es) 2014-09-22
DK1765844T3 (da) 2014-09-01
EP1765844A2 (en) 2007-03-28
JP5044750B2 (ja) 2012-10-10
AU2005254790B2 (en) 2012-02-23
EP1765844B1 (en) 2014-07-30
US8153609B2 (en) 2012-04-10
WO2005123755A3 (en) 2006-04-06
JP2008502673A (ja) 2008-01-31
AU2005254790A1 (en) 2005-12-29
US20080293665A1 (en) 2008-11-27
CA2568907C (en) 2015-06-09
CA2568907A1 (en) 2005-12-29
WO2005123755A2 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
GB0405937D0 (en) Compounds
GB0413726D0 (en) Compounds
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0408777D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403267D0 (en) Compounds
GB0401654D0 (en) Compounds
GB0403990D0 (en) Compounds
GB0403998D0 (en) Compounds
GB0405270D0 (en) Compounds
GB0403334D0 (en) Compounds
GB0404083D0 (en) Compounds
GB0404084D0 (en) Compounds
GB0403993D0 (en) Compounds
GB0408774D0 (en) Compounds
GB0401657D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)